Table 3.

Adverse events not reported in any of 17,069 patients aged 5 – 17 years after montelukast primary exposures reported to NPDS for calendar years 2000 – 2016.

AST or ALT elevation > 100

Ataxia

Cardiac arrest

Dysrhythmia (Ventricular tachycardia/fibrillation/other)

Esophageal injury

Hyperventilation or tachypnea

Melena

Muscle weakness

Renal failure

Respiratory arrest

Rhabdomyolysis

Seizure (singe, multiple or status epilepticus)

Abbreviation: AST, aspartate aminotransferase; ALT, alanine aminotransferase; NPDS, National Poison Data System